Cover storyDiscover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.
Fosun Pharma funds a HK$1B H-share buyback by selling ~6% of Gland Pharma for US$294M, raising questions for Gland's CDMO partners.
Indian Immunologicals denies producing substandard Abhayrab vials found in Delhi, submitting full batch and distribution records to CDSCO on 14 August 2026.
Rezubio completes first-cohort dosing of RZ-520 after securing parallel FDA and NMPA IND clearances for its inhaled chronic respiratory disease candidate.
At GPACTS 2026, Chakravarthi AVPS declared data integrity, not scale, as India's pharma competitive advantage amid FDA, EMA scrutiny and AI-driven manufacturing.
Latest edition
Interview
Interview20260622153015.png&w=1920&q=75&dpl=dpl_CE3VACNCZ5AoAf3CQ76nP9jikDry)
Interview
Podcast
Sep 28
Oct 06
Nov 18From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.
Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
20260804110923.webp&w=1920&q=75&dpl=dpl_CE3VACNCZ5AoAf3CQ76nP9jikDry)
